Does Dr. EMAD ABUHAMDA have financial conflicts of interest?

Dr. EMAD ABUHAMDA (MD) has received a total of $5,836 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $5,836 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. EMAD ABUHAMDA?

According to CMS Open Payments data, Dr. EMAD ABUHAMDA received funding from OLYMPUS CORPORATION OF THE AMERICAS ($2,224), BOSTON SCIENTIFIC CORPORATION ($1,304), and MAUNA KEA TECHNOLOGIES ($842).

Does Dr. EMAD ABUHAMDA receive research grants or speaking fees?

Dr. EMAD ABUHAMDA has received $5,836 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. EMAD ABUHAMDA

MDReal-Time Hydrated

Specialty: Internal Medicine, Gastroenterology

Practice Location: ALEXANDRIA, VA 22310

NPI Number: 1649228099

LIFETIME INDUSTRY VALUE

$5,836

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABUHAMDA is a verified Internal Medicine, Gastroenterology practitioner based in ALEXANDRIA, VA.

Between 2021 and 2024, Dr. ABUHAMDA had an overall industry promotional and research financial footprint of $5,836 as recorded in the federal CMS Open Payments database.

$5,836 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABUHAMDA's primary funding source is OLYMPUS CORPORATION OF THE AMERICAS, which accounts for $2,224 (representing 38.1% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

OLYMPUS CORPORATION OF THE AMERICAS

Rank 1

$2,224

38.1%

BOSTON SCIENTIFIC CORPORATION

Rank 2

$1,304

22.3%

MAUNA KEA TECHNOLOGIES

Rank 3

$842

14.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.